Stock Comparison
DXCM vs MDT
DexCom Inc and Medtronic PLC side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$27.07B
$103.66B
P/E (TTM)
30.1
21.7
Forward P/E
26.8
13.6
Price/Sales
5.6
2.9
Price/Book
9.0
2.1
EV/EBITDA
17.2
12.5
Dividend Yield
—
3.56%
Profitability
Net Margin
19.30%
13.20%
Operating Margin
21.40%
22.10%
Return on Equity
35.60%
9.84%
Return on Assets
9.65%
4.92%
Growth (YoY)
Revenue Growth
15.00%
9.90%
Earnings Growth
92.20%
18.30%
Price & Risk
Beta
1.4
0.6
52-Week High
$89.98
$103.76
52-Week Low
$54.11
$72.65
Analyst Target
$85.24
$98.00
Compare DXCM and MDT your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.